Fumouze Diagnostics will be the exclusive third-party distributor of Diamedix and Delta Biologicals’ suite of diagnostic tests in France. The initial term of the agreement is three years.

“As the international market for diagnostics increases in importance, one of our goals for 2010 is to increase our presence in key countries in Europe and South America,” remarks Charles Struby, Ph.D., CEO and president of IVAX Diagnostics, the parent company of Diamedix and Delta Biologicals.

IVAX Diagnostics, headquartered in Miami, is an in vitro diagnostics company that develops, manufactures, and distributes reagents, test kits, and instrumentation through its two U.S. subsidiaries, Diamedix and ImmunoVision, as well as its Italian subsidiary, Delta Biologicals. Diamedix and Delta Biologicals have a combined suite of products that includes more than 200 diagnostics tests in the areas of infectious disease, autoimmune disease, and allergies. Delta Biologicals also manufactures a line of instruments for use in clinical and hospital laboratories.

Previous articleGSK to Use Gentronix’ GreenScreen HC and BlueScreen HC Genotoxicity Assays
Next articleXcellerex to Develop Single-Use Manufacturing Technology for Humacyte’s Vascular Grafts